Teneligliptin
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.
Teneligliptin Product Information
Teneligliptin is listed under API and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Teneligliptin. The product is supplied by Clearsynth under CAT No. CS-T-43286.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Teneligliptin
CAS No.
760937-92-6
CAT No.
CS-T-43286
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C22H30N6OS
Molecular Weight
426.58
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for accurate information.
Description
Regulatory Description
Teneligliptin is supplied with detailed characterization data compliant with regulatory guideline. Teneligliptin can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Teneligliptin.
Overview
"Teneligliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that is used to treat type 2 diabetes. Tenegliptin is eliminated from the via excretion, and has a half-life of 24.2 hours in the human body."
Synonyms
Teneligliptin
Application Notes
"Teneligliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that is used to treat type 2 diabetes. Tenegliptin is eliminated from the via excretion, and has a half-life of 24.2 hours in the human body."
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.